Cargando…
Clinical Performance Evaluation of the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Assay
SARS-CoV-2 infections may present with various symptoms that are similar to those of other respiratory diseases. For this reason, the need for simultaneous detection of at least RSV and influenza viruses together with SARS-CoV-2 was evident from the early stages of the pandemic. In the present study...
Autores principales: | Meletis, Georgios, Tychala, Areti, Gkeka, Ioanna, Gkotzia, Athanasia, Triantafyllou, Aikaterini, Pappa, Styliani, Exindari, Maria, Gioula, Georgia, Papa, Anna, Skoura, Lemonia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777658/ https://www.ncbi.nlm.nih.gov/pubmed/36553208 http://dx.doi.org/10.3390/diagnostics12123201 |
Ejemplares similares
-
Dataset from the comparative evaluation of the STANDARD M10 point-of-care analyzer versus the NeuMoDx assay for the molecular diagnosis of SARS-CoV-2
por: Meletis, Georgios, et al.
Publicado: (2022) -
Evaluation of the respiratory NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage and Alinity m Resp-4-Plex assays
por: Quinton, Mikayla, et al.
Publicado: (2022) -
Negative Predictive Value of the Rapid Test Ag 2019-nCoV During the Predominance of Omicron over the Delta Variant and Implications in the Emergency Department
por: Fyntanidou, Barbara, et al.
Publicado: (2022) -
Multicenter evaluation of the NeuMoDx™ SARS-CoV-2 Test
por: Mostafa, Heba H., et al.
Publicado: (2020) -
Evaluation of the QuantiFERON SARS-CoV-2 assay to assess cellular immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in individuals with low and high humoral response
por: Tychala, Areti, et al.
Publicado: (2021)